Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GYRE — GYRE THERAPEUTICS, INC. SEC Filings | FilingIndex

GYRENasdaq

GYRE THERAPEUTICS, INC.

Pharmaceutical Preparations · DE · CIK 1124105

Develops and commercializes small-molecule therapies for organ fibrosis and inflammatory diseases

red 8-K · 90d

+ Watch View on EDGAR ↗

$575M

Market cap

$6.59

Last close

+2.2%

1D

+7.5%

5D

61K

Volume

Price · last 40 sessions-16.8%

May 4L $5.56 · H $8.04Jun 30

386

Total filings

Jun 16, 2026

Last filing

12/31

Fiscal year end

All 8-K · 212 10-Q · 40 SC 13G · 34 DEFA14A · 26 424B5 · 14 10-K · 13 SC 13D · 12 DEF 14A · 12

SC 13DSC 13DSep 6, 2024 SC 13DSC 13DSep 6, 2024 SC 13DSC 13DJan 5, 2023 SC 13DSC 13DJun 21, 2022 SC 13DSC 13DJul 24, 2019 SC 13D

Similar companies

Comparable business profile · signals at a glance

CTNMContineum Therapeutics, Inc.$444.2M+9.3%ZLABZai Lab Ltd$1.9B+3.2%SIONSionna Therapeutics, Inc.$1.6B+2.4%RNTXRein Therapeutics, Inc.$81.9M0.0%MDGLMADRIGAL PHARMACEUTICALS, INC.

THE SCHEDULE 13D

Jul 23, 2019

SC 13DSC 13DAug 31, 2015

SC 13DSC 13DAug 31, 2015

SC 13DSCHEDULE 13DAug 31, 2015

SC 13DSC 13DAug 28, 2015

SC 13DAMENDMENT NO. 1 TO SCHEDULE 13DFeb 10, 2015

SC 13DSCHEDULE 13DSep 5, 2014

$11.1B

+1.8%

KROSKeros Therapeutics, Inc.$200.9M-2.1%